Press Releases
 
Aus and NZ oncologists can provide personalised cancer treatments using Caris Molecular Intelligence

, 13 November 2017 -- Caris Life Sciences provides the most comprehensive genomic tumour profiling plus (CGP+) of DNA, RNA and proteins enabling personalised therapy decisions across immunotherapy, targeted therapy and chemotherapy.

Caris Life Sciences provides the most comprehensive genomic tumour profiling plus (CGP+) of DNA, RNA and proteins enabling personalised therapy decisions across immunotherapy, targeted therapy and chemotherapy. Since its foundation in 2008 Caris has collected clinical outcomes that show the superiority of CMI.1,2

Precision Oncology is proud to be the new exclusive distributor for Caris Molecular Intelligence in Australia and New Zealand.

More than 6,000 oncologists from 58 countries have used Caris Life Sciences to profile more than 120,000 tumours worldwide. With Caris Molecular Intelligence and the very latest cancer target (biomarker) research, increasing numbers of oncologists are choosing the treatments that are likely to work for each patient’s cancer.

Better information can lead to better treatment decisions

Standard cancer treatment is based largely on the original location of the tumour, such as the breast or lungs. This approach may not always produce optimal results.

In contrast, Caris Molecular Intelligence matches evidence-guided cancer treatments with the molecular profile of each tumour. A molecular profile reveals the unique characteristics of a person’s cancer at the molecular level, providing doctors with knowledge about which treatments are most likely to produce the best results, including treatments that may not have been previously considered. Molecular profiling may also help doctors avoid treatments that are ineffective, unnecessary, and potentially harmful.

Molecular profiling provides the information that helps oncologists to personalise treatment plans for individual patients. It can be particularly valuable for people who have run out of standard treatment options, for those with rare or aggressive cancer, or if there are multiple treatment options available for that type of cancer.

To find out more about how Caris Molecular Intelligence can help oncologists and patients, contact Precision Oncology today.

References

1. Capdevila J, Rojo F, Gonzalez-Martin A, et al. Molecular profiling for clinical decision making in advanced cancer: a clinical appraisal. Journal of Cancer Research and Treatment. 2017; 5(3): 77-85. [Full text]

2. Ussia G, Leonard R, Janssens J. Multi-platform tumour profiling delivers the highest clinical utility and improves patient outcomes in today’s routine clinical practice. International Journal of Surgery & Surgical Procedures. 2016, 1: 107. [Full text]

Contact
Elizabeth Tysoe, General Manager
Company: Precision Oncology
Address: Subiaco, Western Australia, Australia
Phone: +61 8 6245 2020
Email:
Website: https://www.precisiononcology.com.au/

# # #


Submitted by suleman, suleman on Monday, 13 November 2017 at 7:50 PM
Category: Health Care & Medical
 
Related News

Antibleeding Gel Market to Reflect Impressive Growth Rate During
Thursday, 21 Jun 2018

Alimentary Tract and Metabolism Market to Witness an Outstanding Growth by 2024
Thursday, 21 Jun 2018

C-Reactive Protein Testing Market is Estimated to Experience a Hike in Growth by 2019
Thursday, 21 Jun 2018

Vascular Closure Devices Market is Set to Witness an Uptick during 2024
Thursday, 21 Jun 2018

Ambulatory Blood Pressure Monitoring Market is Estimated to Expand at a Robust CAGR over 2020
Thursday, 21 Jun 2018

Related Events

Mayo Clinic Hospital Medicine for NPs and PAs
Wednesday, 20 Jun 2018

2018 Vascular Annual Meeting - Boston | Society for Vascular Surgery
Wednesday, 20 Jun 2018

EuroPerio9
Wednesday, 20 Jun 2018

Transforming Women's Health: Challenges and New Frontiers
Thursday, 21 Jun 2018

Transforming Women’s Health: Challenges and New Frontiers
Thursday, 21 Jun 2018

Latest News

Antibleeding Gel Market to Reflect Impressive Growth Rate During
Thursday, 21 Jun 2018

Alimentary Tract and Metabolism Market to Witness an Outstanding Growth by 2024
Thursday, 21 Jun 2018

C-Reactive Protein Testing Market is Estimated to Experience a Hike in Growth by 2019
Thursday, 21 Jun 2018

Advantages of Online Flowers Delivery Services
Thursday, 21 Jun 2018

Vascular Closure Devices Market is Set to Witness an Uptick during 2024
Thursday, 21 Jun 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Thursday, 21 June 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Mayo Clinic Hospital Medicine for NPs and PAs
  • 2018 Vascular Annual Meeting - Boston | Society for Vascular Surgery
  • Palo Alto Networks: Crab Feast and Tech Seminar with SLAIT, Palo Alto and Duo
  • Palo Alto Networks: Curso comercial para Canales: Nuevas Soluciones
  • EuroPerio9

  • Latest Jobs
    Sorry, there are currently no entries posted here.